184 related articles for article (PubMed ID: 24569264)
1. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
[TBL] [Abstract][Full Text] [Related]
2. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.
Takai A; Toyoshima T; Uemura M; Kitawaki Y; Marusawa H; Hiai H; Yamada S; Okazaki IM; Honjo T; Chiba T; Kinoshita K
Oncogene; 2009 Jan; 28(4):469-78. PubMed ID: 18997814
[TBL] [Abstract][Full Text] [Related]
3. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.
Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T
Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440
[TBL] [Abstract][Full Text] [Related]
4. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.
Naas T; Ghorbani M; Alvarez-Maya I; Lapner M; Kothary R; De Repentigny Y; Gomes S; Babiuk L; Giulivi A; Soare C; Azizi A; Diaz-Mitoma F
J Gen Virol; 2005 Aug; 86(Pt 8):2185-2196. PubMed ID: 16033966
[TBL] [Abstract][Full Text] [Related]
5. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling.
Endo Y; Marusawa H; Kinoshita K; Morisawa T; Sakurai T; Okazaki IM; Watashi K; Shimotohno K; Honjo T; Chiba T
Oncogene; 2007 Aug; 26(38):5587-95. PubMed ID: 17404578
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
Tiwari I; Yoon MH; Park BJ; Jang KL
Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific sensitivity to AID expression in transgenic mouse models.
Rucci F; Cattaneo L; Marrella V; Sacco MG; Sobacchi C; Lucchini F; Nicola S; Della Bella S; Villa ML; Imberti L; Gentili F; Montagna C; Tiveron C; Tatangelo L; Facchetti F; Vezzoni P; Villa A
Gene; 2006 Aug; 377():150-8. PubMed ID: 16787714
[TBL] [Abstract][Full Text] [Related]
9. [Differential display of messenger RNA and identification of selenocysteine lyase gene in hepatocellular carcinoma cells transiently expressing hepatitis C virus core protein].
Yepes JO; Luz Gunturiz M; Henao LF; Navas MC; Balcázar N; Gómez LA
Biomedica; 2006 Jun; 26(2):194-205. PubMed ID: 16925092
[TBL] [Abstract][Full Text] [Related]
10. Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.
Kim SK; Marusawa H; Eso Y; Chiba T; Kudo M
Dig Dis; 2013; 31(5-6):454-8. PubMed ID: 24281020
[TBL] [Abstract][Full Text] [Related]
11. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
12. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice.
Wang AG; Moon HB; Lee YH; Yu SL; Kwon HJ; Han YH; Fang W; Lee TH; Jang KL; Kim SK; Yu DY; Lee DS
Exp Mol Med; 2004 Dec; 36(6):588-93. PubMed ID: 15675043
[TBL] [Abstract][Full Text] [Related]
16. Progesterone inhibits activation-induced deaminase by binding to the promoter.
Pauklin S; Petersen-Mahrt SK
J Immunol; 2009 Jul; 183(2):1238-44. PubMed ID: 19553525
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
Satoh K; Takahashi H; Matsuda C; Tanaka T; Miyasaka M; Zeniya M; Kohara M
J Med Virol; 2010 Sep; 82(9):1545-53. PubMed ID: 20648608
[TBL] [Abstract][Full Text] [Related]
20. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
